MORGAN STANLEY PLC/PUT/PFIZER INC/32.5/0.1/20.09.24 | Market Closed - Börse Stuttgart 20:28:38 05/07/2024 BST | ||
| 0.46 EUR | +4.55% |
|
| 3 months | -23.33% | ||
| 6 months | +4.55% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 0.46 | +4.55% |
| 04/07/24 | 0.44 | -8.33% |
| 03/07/24 | 0.48 | +2.13% |
| 02/07/24 | 0.47 | +6.82% |
| 01/07/24 | 0.44 | -4.35% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 08:28 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Morgan Stanley |
| WKN | MB3YJG |
| ISIN | DE000MB3YJG4 |
| Date issued | 27/02/2023 |
| Strike | 32.5 $ |
| Maturity | 20/09/2024 (76 Days) |
| Parity | 10 : 1 |
| Emission price | 0.21 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.72 € |
|---|---|
| Lowest since issue | 0.119 € |
| Spread | 0.01 € |
| Spread % | 2.17% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.05
USD
Average target price
31.92
USD
Spread / Average Target
+13.78%
- Stock Market
- Warrants
- Warrant
